Hot flushes in healthy aging men differ from those in men with prostate cancer and in menopausal women

References

• Hammar M, Berg G, Fåhraeus L, Larsson-Cohn U. Climacteric symptoms in an unselected sample of Swedish women. Maturitas 1984;6:345–350.
   PubMed Web of Science ®Google Scholar
• McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103–115.
   PubMed Web of Science ®Google Scholar
• Huggins C, Stevens RC, Hodges CV. Studies on prostatic cancer. II. The effect of castration of advanced carcinoma of the prostate gland. Arch Surg 1941;43:209–223.
   Google Scholar
• McCullagh EP, Renshaw JF. The effect of castration in the adult male. JAMA 1934;13:1140–1143.
   Google Scholar
• Feldman JM, Postlethwaite RW, Glenn JF. Hot flashes and sweats in men with testicular insufficiency. Arch Intern Med 1976;136:606–608.
   PubMed Web of Science ®Google Scholar
• Spetz AC, Fredriksson MG, Hammar ML. Hot flushes in a male population aged 55, 65, and 75 years, living in the community of Linköping, Sweden. Menopause 2003;10:81–87.
   PubMed Web of Science ®Google Scholar
• Freedman RR. Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 1989;26:573–579.
   PubMed Web of Science ®Google Scholar
• Frödin T, Alund G, Varenhorst E. Measurement of skin blood-flow and water evaporation as a means of objectively assessing hot flushes after orchidectomy in patients with prostatic cancer. Prostate 1985;7:203–208.
   PubMed Web of Science ®Google Scholar
• Ginsburg J, O’Reilly B. Climacteric flushing in a man. Br Med J (Clin Res Ed) 1983;287:262.
   PubMed Web of Science ®Google Scholar
• Spetz AC, Pettersson B, Varenhorst E, Theodorsson E, Thorell LH, Hammar M. Momentary increase in plasma calcitonin gene-related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate. J Urol 2001;166:1720–1723.
   PubMed Web of Science ®Google Scholar
• Collin E, Frechilla D, Pohl M, Bourgoin S, Le Bars D, Hamon M, Cesselin F. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Brain Res 1993;609:211–222.
   PubMed Web of Science ®Google Scholar
• Uddman R, Edvinsson L, Ekblad E, Håkanson R, Sundler F. Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept 1986;15:1–23.
   PubMedGoogle Scholar
• Jernbeck J, Edner M, Dalsgaard CJ, Pernow B. The effect of calcitonin gene-related peptide (CGRP) on human forearm blood flow. Clin Physiol 1990;10:335–343.
   PubMedGoogle Scholar
• Chen JT, Hirai Y, Seimiya Y, Hasumi K, Shiraki M. Menopausal flushes and calcitonin-gene-related peptide. Lancet 1993;342:49.
   PubMed Web of Science ®Google Scholar
• Valentini A, Petraglia F, De Vita D, Nappi C, Margutti A, degli Uberti EC, Genazzani AR. Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. Am J Obstet Gynecol 1996;175:638–642.
   PubMed Web of Science ®Google Scholar
• Wyon YA, Spetz AC, Theodorsson GE, Hammar ML. Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women. Menopause 2000;7:25–30.
   PubMed Web of Science ®Google Scholar
• Vermeulen A. Clinical review 24: Androgens in the aging male. J Clin Endocrinol Metab 1991;73:221–224.
   PubMed Web of Science ®Google Scholar
• Theodorsson-Norheim E, Hemsén A, Brodin E, Lundberg JM. Sample handling techniques when analyzing regulatory peptides. Life Sci 1987;41:845–848.
   PubMed Web of Science ®Google Scholar
• Lykken DT, Venables PH. Direct measurement of skin conductance: a proposal for standardization. Psychophysiology 1971;8:656–672.
   PubMed Web of Science ®Google Scholar
• Freedman RR, Norton D, Woodward S, Cornélissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995;80:2354–2358.
   PubMed Web of Science ®Google Scholar
• Freedman RR, Woodward S. Core body temperature during menopausal hot flushes. Fertil Steril 1996;65:1141–1144.
   PubMed Web of Science ®Google Scholar
• Hanisch LJ, Mao JJ, Gehrman PR, Vaughn DJ, Coyne JC. Increases in core body temperature precede hot flashes in a prostate cancer patient. Psychooncology 2009;18:564–567.
   PubMed Web of Science ®Google Scholar
• T’Sjoen G, Goemaere S, De Meyere M, Kaufman JM. Perception of males’ aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 2004;29:201–214.
   PubMed Web of Science ®Google Scholar
• Heinemann L, Zimmermann T, Vermeulen A, Thiel C, Hummel W. A new “aging males” symptoms rating scale. Aging Male 1999;2:105.
   Google Scholar
• Miwa Y, Kaneda T, Yokoyama O. Correlation between the aging males symptoms scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men. J Sex Med 2006;3:723–726.
   PubMed Web of Science ®Google Scholar
• Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Takada S, Koga M, et al. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int J Impot Res 2005;17:259–263.
   PubMed Web of Science ®Google Scholar
• Frisk J, Spetz AC, Hjertberg H, Petersson B, Hammar M. Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer—a prospective multicenter study with long-term follow-up. Eur Urol 2009;55:156–163.
   PubMed Web of Science ®Google Scholar
• Frisk J. Managing hot flushes in men after prostate cancer—a systematic review. Maturitas 2010;65:15–22.
   PubMed Web of Science ®Google Scholar
• Ashamalla H, Jiang ML, Guirguis A, Peluso F, Ashamalla M. Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy. Int J Radiat Oncol Biol Phys 2011;79:1358–1363.
   PubMed Web of Science ®Google Scholar
• Irani J, Salomon L, Oba R, Bouchard P, Mottet N. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol 2010;11:147–154.
   PubMed Web of Science ®Google Scholar